Cargando…

Comparison of valvuloplasty and replacement for surgical treatment of tricuspid infective endocarditis

BACKGROUND: Owing to the increase in both intravenous drug injections and intracardiac and vascular interventional treatments among drug users, the incidence of infective endocarditis (IE) involving the tricuspid valve, which sits between the two right heart chambers, has gradually increased. This s...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Linfeng, Chen, Xiaodong, He, Jian, Lin, Sixian, Chen, Xingfeng, Wu, Qingsong, Chen, Ling, Zhuang, Jingxiang, Qiu, Zhihuang, Chen, Liangwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148397/
https://www.ncbi.nlm.nih.gov/pubmed/37118668
http://dx.doi.org/10.1186/s12872-023-03248-1
_version_ 1785034966571155456
author Xie, Linfeng
Chen, Xiaodong
He, Jian
Lin, Sixian
Chen, Xingfeng
Wu, Qingsong
Chen, Ling
Zhuang, Jingxiang
Qiu, Zhihuang
Chen, Liangwan
author_facet Xie, Linfeng
Chen, Xiaodong
He, Jian
Lin, Sixian
Chen, Xingfeng
Wu, Qingsong
Chen, Ling
Zhuang, Jingxiang
Qiu, Zhihuang
Chen, Liangwan
author_sort Xie, Linfeng
collection PubMed
description BACKGROUND: Owing to the increase in both intravenous drug injections and intracardiac and vascular interventional treatments among drug users, the incidence of infective endocarditis (IE) involving the tricuspid valve, which sits between the two right heart chambers, has gradually increased. This study aimed to compare the clinical outcomes of different surgical procedures for tricuspid infective endocarditis (TIE). METHODS: We retrospectively analyzed fifty-six patients who underwent tricuspid valve surgery at our hospital from January 2006 to August 2019. All patients were diagnosed with TIE and indicated a need for surgery. Perioperative and follow-up data were collected to summarize and analyze the clinical outcomes of different surgical approaches, including tricuspid valvuloplasty (TVP) and tricuspid valve replacement (TVR) for TIE. RESULTS: Cardiopulmonary bypass (CPB) time, aortic cross-clamp (ACC) time, postoperative mechanical ventilation time, and intensive care unit (ICU) stay time were shorter in the TVP group than in the TVR group. Additionally, the incidence of red blood cell transfusion and postoperative complications was lower in the TVP group than in the TVR group. The postoperative 30-day mortality rates were similar between both the groups. Fifty-two patients were followed up for an average of 5.50 ± 3.79 years. The postoperative 3-, 5-, and 7-year survival rates were 100%, 100%, and 95.5% in the TVP group and 96.7%, 96.7%, and 96.7% in the TVR group, respectively. The 5-year and 10-year reoperation rates were 0% and 0% in the TVP group and 6.7% and 20% in the TVR group, respectively. CONCLUSION: Both TVR and TVP for TIE significantly improved the functional status of the heart with satisfactory efficacy. TVP was found to be superior to TVR in reducing the need for postoperative blood transfusions, reducing the risk of postoperative complications, and reducing the need for long-term reoperations.
format Online
Article
Text
id pubmed-10148397
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-101483972023-04-30 Comparison of valvuloplasty and replacement for surgical treatment of tricuspid infective endocarditis Xie, Linfeng Chen, Xiaodong He, Jian Lin, Sixian Chen, Xingfeng Wu, Qingsong Chen, Ling Zhuang, Jingxiang Qiu, Zhihuang Chen, Liangwan BMC Cardiovasc Disord Research BACKGROUND: Owing to the increase in both intravenous drug injections and intracardiac and vascular interventional treatments among drug users, the incidence of infective endocarditis (IE) involving the tricuspid valve, which sits between the two right heart chambers, has gradually increased. This study aimed to compare the clinical outcomes of different surgical procedures for tricuspid infective endocarditis (TIE). METHODS: We retrospectively analyzed fifty-six patients who underwent tricuspid valve surgery at our hospital from January 2006 to August 2019. All patients were diagnosed with TIE and indicated a need for surgery. Perioperative and follow-up data were collected to summarize and analyze the clinical outcomes of different surgical approaches, including tricuspid valvuloplasty (TVP) and tricuspid valve replacement (TVR) for TIE. RESULTS: Cardiopulmonary bypass (CPB) time, aortic cross-clamp (ACC) time, postoperative mechanical ventilation time, and intensive care unit (ICU) stay time were shorter in the TVP group than in the TVR group. Additionally, the incidence of red blood cell transfusion and postoperative complications was lower in the TVP group than in the TVR group. The postoperative 30-day mortality rates were similar between both the groups. Fifty-two patients were followed up for an average of 5.50 ± 3.79 years. The postoperative 3-, 5-, and 7-year survival rates were 100%, 100%, and 95.5% in the TVP group and 96.7%, 96.7%, and 96.7% in the TVR group, respectively. The 5-year and 10-year reoperation rates were 0% and 0% in the TVP group and 6.7% and 20% in the TVR group, respectively. CONCLUSION: Both TVR and TVP for TIE significantly improved the functional status of the heart with satisfactory efficacy. TVP was found to be superior to TVR in reducing the need for postoperative blood transfusions, reducing the risk of postoperative complications, and reducing the need for long-term reoperations. BioMed Central 2023-04-28 /pmc/articles/PMC10148397/ /pubmed/37118668 http://dx.doi.org/10.1186/s12872-023-03248-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Xie, Linfeng
Chen, Xiaodong
He, Jian
Lin, Sixian
Chen, Xingfeng
Wu, Qingsong
Chen, Ling
Zhuang, Jingxiang
Qiu, Zhihuang
Chen, Liangwan
Comparison of valvuloplasty and replacement for surgical treatment of tricuspid infective endocarditis
title Comparison of valvuloplasty and replacement for surgical treatment of tricuspid infective endocarditis
title_full Comparison of valvuloplasty and replacement for surgical treatment of tricuspid infective endocarditis
title_fullStr Comparison of valvuloplasty and replacement for surgical treatment of tricuspid infective endocarditis
title_full_unstemmed Comparison of valvuloplasty and replacement for surgical treatment of tricuspid infective endocarditis
title_short Comparison of valvuloplasty and replacement for surgical treatment of tricuspid infective endocarditis
title_sort comparison of valvuloplasty and replacement for surgical treatment of tricuspid infective endocarditis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148397/
https://www.ncbi.nlm.nih.gov/pubmed/37118668
http://dx.doi.org/10.1186/s12872-023-03248-1
work_keys_str_mv AT xielinfeng comparisonofvalvuloplastyandreplacementforsurgicaltreatmentoftricuspidinfectiveendocarditis
AT chenxiaodong comparisonofvalvuloplastyandreplacementforsurgicaltreatmentoftricuspidinfectiveendocarditis
AT hejian comparisonofvalvuloplastyandreplacementforsurgicaltreatmentoftricuspidinfectiveendocarditis
AT linsixian comparisonofvalvuloplastyandreplacementforsurgicaltreatmentoftricuspidinfectiveendocarditis
AT chenxingfeng comparisonofvalvuloplastyandreplacementforsurgicaltreatmentoftricuspidinfectiveendocarditis
AT wuqingsong comparisonofvalvuloplastyandreplacementforsurgicaltreatmentoftricuspidinfectiveendocarditis
AT chenling comparisonofvalvuloplastyandreplacementforsurgicaltreatmentoftricuspidinfectiveendocarditis
AT zhuangjingxiang comparisonofvalvuloplastyandreplacementforsurgicaltreatmentoftricuspidinfectiveendocarditis
AT qiuzhihuang comparisonofvalvuloplastyandreplacementforsurgicaltreatmentoftricuspidinfectiveendocarditis
AT chenliangwan comparisonofvalvuloplastyandreplacementforsurgicaltreatmentoftricuspidinfectiveendocarditis